DSY · Class II · 21 CFR 870.3450

FDA Product Code DSY: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

FDA product code DSY covers vascular graft prostheses with a diameter of 6mm or greater.

These synthetic conduits — typically made from Dacron (polyester) or ePTFE — replace or bypass diseased segments of the aorta, iliac, or femoral arteries in open vascular surgery. Large-diameter grafts are used in aortic aneurysm repair and aortoiliac occlusive disease.

DSY devices are Class II medical devices, regulated under 21 CFR 870.3450 and reviewed by the FDA Cardiovascular panel.

Leading manufacturers include C.R. Bard, Inc., Peca Labs and W.L. Gore & Associates, Inc..

188
Total
186
Cleared
114d
Avg days
1976
Since
Declining activity - 4 submissions in the last 2 years vs 8 in the prior period
Review times increasing: avg 210d recently vs 112d historically

FDA 510(k) Cleared Prosthesis, Vascular Graft, Of 6mm And Greater Diameter Devices (Product Code DSY)

188 devices
1–24 of 188
Cleared Apr 27, 2026
Fusion Bioline Vascular Graft
K252445
Maquet Cardiovascular, LLC
Cardiovascular · 266d
Cleared Oct 20, 2025
Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)
K252277
Vascular Flow Technologies Limited
Cardiovascular · 90d
Cleared Feb 27, 2025
Gelweave™ Vascular Prostheses
K241550
Vascutek, Ltd.
Cardiovascular · 272d
Cleared Nov 15, 2024
Gelsoft™ Plus Vascular Prostheses
K241070
Vascutek, Ltd.
Cardiovascular · 210d
Cleared Mar 28, 2024
Advanta VXT Vascular Graft, Flixene Vascular Graft
K231972
Atrium Medical Corporation
Cardiovascular · 269d
Cleared Mar 01, 2024
GORE® PROPATEN® Vascular Graft
K240083
W.L. Gore & Associates, Inc.
Cardiovascular · 50d
Cleared Jan 17, 2024
exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts
K233783
Peca Labs, Inc.
Cardiovascular · 51d
Cleared Jan 09, 2024
GORE® PROPATEN® Vascular Graft
K232312
W.L. Gore & Associates, Inc.
Cardiovascular · 160d
Cleared Dec 19, 2023
GORE® ACUSEAL Vascular Graft
K233551
W.L. Gore & Associates, Inc.
Cardiovascular · 46d
Cleared Jun 23, 2023
GORE® ACUSEAL Vascular Graft
K231505
W.L. Gore & Associates, Inc.
Cardiovascular · 30d
Cleared Aug 15, 2022
HeRO Graft
K213845
Merit Medical Systems, Inc.
Cardiovascular · 249d
Cleared Aug 04, 2022
exGraft, exGraft Carbon
K221628
Peca Labs
Cardiovascular · 59d
Cleared May 25, 2021
HeRO Graft, HeRO Adapter
K203724
Merit Medical Systems, Inc.
Cardiovascular · 155d
Cleared Apr 06, 2021
Vascutek Gelsoft Plus ERS Vascular Graft
K202703
Vascutek, Ltd.
Cardiovascular · 202d
Cleared Dec 11, 2020
exGraft ePTFE Vascular Graft, exGraft Carbon ePTFE Vascular Graft
K202471
Peca Labs
Cardiovascular · 105d
Cleared Apr 22, 2019
exGraft, exGraft Carbon
K183613
Peca Labs
Cardiovascular · 117d
Cleared Aug 21, 2018
exGraft, exGraft Carbon ePTFE Vascular Grafts
K180957
Peca Labs
Cardiovascular · 131d
Cleared Nov 30, 2017
HeRO Graft
K172637
Merit Medical Systems, Inc.
Cardiovascular · 90d
Cleared Jan 17, 2012
EXXCEL SOFT EPTEE VASCULAR GRAFT-STANDARD WALL,THIN WALL
K113101
Boston Scientific Corporation
Cardiovascular · 90d
Cleared Jan 06, 2006
EXXCEL AND EXXCEL SOFT EPTFE VASCULAR GRAFTS, MICROVEL DOUBLE VELOUR KNITTED VASCULAR GRAFTS, WOVEN DOUBLE VELOUR WOVEN
K052964
Boston Scientific Corp
Cardiovascular · 77d
Cleared Jun 19, 1996
BARD GRAFT SIZER
K961134
C.R. Bard, Inc.
Cardiovascular · 90d
Cleared Dec 07, 1995
BARD EXPANDED PTFE VASCULAR GRAFT(MODIFICATION)
K954582
C.R. Bard, Inc.
Cardiovascular · 91d
Cleared Jun 02, 1994
BARD(R) EXPANDED PTFE VASCULAR GRAFT
K940816
C.R. Bard, Inc.
Cardiovascular · 100d
Cleared Jan 26, 1994
BAXTER REINFORCED EXPANDED PTFE VASCULAR GRAFT
K933590
Baxter Healthcare Corp
Cardiovascular · 184d

About Product Code DSY - Regulatory Context

510(k) Submission Activity

188 total 510(k) submissions under product code DSY since 1976, with 186 receiving FDA clearance (average review time: 114 days).

Submission volume has declined in recent years - 4 submissions in the last 24 months compared to 8 in the prior period.

FDA 510(k) Review Time - DSY Product Code

Recent submissions under DSY have taken an average of 210 days to reach a decision - up from 112 days historically. Manufacturers should account for longer review timelines in current project planning.

DSY devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →